Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2026)

Recursion Pharmaceuticals (RXRX) has 4 years of Tax Rate data on file, last reported at 3.77% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 369.0% year-over-year to 3.77%; the trailing twelve-month figure through Mar 2026 stood at 0.81% (up 72.0% YoY), and the FY2025 full-year result was 0.02%, down 22.0% from the prior year.
• Tax Rate for Q1 2026 stood at 3.77%, up from 0.02% in the prior quarter.
• Across five years, Tax Rate topped out at 4.19% in Q4 2023 and bottomed at 0.17% in Q3 2024.
• The 4-year median for Tax Rate is 0.08% (2025), against an average of 1.02%.
• The widest annual swing landed in 2024, when Tax Rate plunged 419 bps; it then surged 369 bps in 2026.
• A 4-year view of Tax Rate shows it stood at 4.19% in 2023, then plunged by 100 bps to 0.0% in 2024, then plunged by 373 bps to 0.02% in 2025, then jumped by 20480 bps to 3.77% in 2026.
• The last three Tax Rate figures came in at 3.77% (Q1 2026), 0.02% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison